MARSHALL WACE, LLP - CELLULAR BIOMEDICINE GROUP I ownership

Back to all holdings Add to watchlist

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 76 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2020. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$392,000
-68.7%
21,315
-68.8%
0.00%
-75.0%
Q3 2020$1,254,000–68,372–0.01%–
 Download
Other shareholders

There were no reported owners of CELLULAR BIOMEDICINE GROUP I in Q3 2020.

NameSharesValueWeighting ↓
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders